Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

21 May 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Organidin NR Articles

Watson files for generic Mucinex

22 April 2009

UK regulator orders infant cough remedy ban for under 2 yr olds

31 March 2008

Adams Resp gets "not-approvable letter" for Mucinex with Codeine

5 November 2007

FDA cracks down on guaifenesin-TR sale

4 June 2007

US FDA tackles unapproved drugs

16 October 2006

Adams set to defend guaifenesin position from competitor

28 August 2006

US FDA: unapproved drug enforcement

10 March 2003

Adams' Mucinex cleared for OTC use in USA

27 January 2003

Single-Digit Profits Growth For B-MS And W-L

5 August 1996

Medeva Shows Its Strength After Failed Merger Talks

26 February 1996

Medeva "Not For Sale" But Is On Track For Growth

24 July 1995

Medeva's 1994 Results Crown Five Years Of Growth

27 March 1995

Cater Wallace Accused Of Ethics Breach

24 October 1994

PROCTER & GAMBLE TO TO CLOSE PLANTS

20 June 1994

MARKET WARMS TO COUGH & COLD SEASON IN USA

1 November 1993

Showing 1-15 of 15 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
  • Elan makes "transformational" acquisitions and a divestment
  • HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
  • Is failure to adopt business process management putting the pharma industry at risk?
  • Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
  • Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
  • Elan makes "transformational" acquisitions and a divestment
  • HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
  • Is failure to adopt business process management putting the pharma industry at risk?
  • Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS